Login
Navigate Fool.com
Will QLTI beat
the market?

QLT, Inc. (USA)

NASDAQ: QLTI

Community Rating: 3 Stars: Appealing

7.82 -0.07 (-0.89%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.82
Previous Close $7.89
Daily Range $7.72 - $7.85
52-Week Range $6.33 - $9.10
Market Cap $395.2M
P/E Ratio -10.12
Dividend (Yield) $0.00 (0.0%)
Volume 35,961
Average Daily Volume 82,094
Current FY EPS -$0.60

How do you think QLTI
will perform against the market?

Top QLTI Bull/Bear Pitches

 

BuffySoro (< 20)
Submitted January 3, 2009

I picked this because of the favorable prospects of the industry, and this looks like a cheap diamond among expensive pebbles.

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted December 11, 2009

QLT's ascent seems to have stuttered at about the 4.75 level although it remains close to its year high. Their only marketed product, Visudyne, is a niche ophthalmologic medication with declining reve … More

1 Replies Reply Report this Post

News & Commentary

Investing 101: Biotech Stocks With Insider Buying

If anyone knows what's going on with a company, it has to be the people who work there.

Valeant Pharma Buys QLT's Eye Treatment Visudyne for $112.5 Million

Three Important Biotech Names

QLT Granted Orphan-Drug Status For Two Retinal Ailments

3 Insider Stocks That Could Pop

Study: QLT Eye Drug With Lucentis Cuts Doctor Visits

Dubai Jitters Rattle Drug Stocks; QLT Gains

3 Stocks Hitting High Notes

These stocks are reaching for the stars.

4-Star Stocks on the Upswing

It can pay to catch rising stars.

5-Star Stocks on the Upswing

Check out these newly minted five-star stocks.

See More QLTI News...

Sector

Healthcare

Industry

Drugs

QLT, Inc. (USA) (QLTI) Description

A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Website: http://www.qltinc.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks